» Articles » PMID: 26258949

Application of β-lactamase Reporter Fusions As an Indicator of Effector Protein Secretion During Infections with the Obligate Intracellular Pathogen Chlamydia Trachomatis

Overview
Journal PLoS One
Date 2015 Aug 11
PMID 26258949
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Chlamydia spp. utilize multiple secretion systems, including the type III secretion system (T3SS), to deploy host-interactive effector proteins into infected host cells. Elucidation of secreted proteins has traditionally required ectopic expression in a surrogate T3SS followed by immunolocalization of endogenous candidate effectors to confirm secretion by chlamydiae. The ability to transform Chlamydia and achieve stable expression of recombinant gene products has enabled a more direct assessment of secretion. We adapted TEM-1 β-lactamase as a reporter system for assessment of chlamydial protein secretion. We provide evidence that this system facilitates visualization of secretion in the context of infection. Specifically, our findings provide definitive evidence that C. trachomatis CT695 is secreted during infection. Follow-up indirect immunofluorescence studies confirmed CT695 secretion and indicate that this effector can be secreted at multiple points during the chlamydial developmental cycle. Our results indicate that the BlaM-fusion reporter assay will allow efficacious identification of novel secreted proteins. Moreover, this approach can easily be adapted to enable more sophisticated studies of the secretion process in Chlamydia.

Citing Articles

A molecular toolkit for heterologous protein secretion across Bacteroides species.

Yeh Y, Kelly V, Rahman Pour R, Sirk S Nat Commun. 2024; 15(1):9741.

PMID: 39528443 PMC: 11554821. DOI: 10.1038/s41467-024-53845-7.


Global mapping of the conventional secreted effector - host interactome reveals CebN interacts with nucleoporins and Rae1 to impede STAT1 nuclear translocation.

Steiert B, Andersen S, McCaslin P, Elwell C, Faris R, Tijerina X bioRxiv. 2024; .

PMID: 38712050 PMC: 11071493. DOI: 10.1101/2024.04.25.587017.


A molecular toolkit for heterologous protein secretion across species.

Yeh Y, Kelly V, Rahman Pour R, Sirk S bioRxiv. 2024; .

PMID: 38168418 PMC: 10760143. DOI: 10.1101/2023.12.14.571725.


Molecular pathogenesis of .

Jury B, Fleming C, Huston W, Luu L Front Cell Infect Microbiol. 2023; 13:1281823.

PMID: 37920447 PMC: 10619736. DOI: 10.3389/fcimb.2023.1281823.


Plasmid-mediated virulence in .

Turman B, Darville T, OConnell C Front Cell Infect Microbiol. 2023; 13:1251135.

PMID: 37662000 PMC: 10469868. DOI: 10.3389/fcimb.2023.1251135.


References
1.
Hower S, Wolf K, Fields K . Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol. 2009; 72(6):1423-37. PMC: 2997736. DOI: 10.1111/j.1365-2958.2009.06732.x. View

2.
Spaeth K, Chen Y, Valdivia R . The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex. PLoS Pathog. 2009; 5(9):e1000579. PMC: 2734247. DOI: 10.1371/journal.ppat.1000579. View

3.
Engstrom P, Nguyen B, Normark J, Nilsson I, Bastidas R, Gylfe A . Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (HemG) and Chlamydia trachomatis infectivity. J Bacteriol. 2013; 195(18):4221-30. PMC: 3754756. DOI: 10.1128/JB.00506-13. View

4.
Caldwell H, Kromhout J, Schachter J . Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun. 1981; 31(3):1161-76. PMC: 351439. DOI: 10.1128/iai.31.3.1161-1176.1981. View

5.
Copenhaver A, Casson C, Nguyen H, Fung T, Duda M, Roy C . Alveolar macrophages and neutrophils are the primary reservoirs for Legionella pneumophila and mediate cytosolic surveillance of type IV secretion. Infect Immun. 2014; 82(10):4325-36. PMC: 4187856. DOI: 10.1128/IAI.01891-14. View